158
Views
23
CrossRef citations to date
0
Altmetric
Original

The Effects of Levetiracetam on Alcohol Consumption in Alcohol-Dependent Subjects: An Open Label Study

, , , , , , , , & show all
Pages 441-447 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Sandhya Devaraj, Sara A Muralles, Chandler E Gill & Edwin Meresh. (2018) Postseizure aphasia in Wernicke’s encephalopathy: a case report and review of literature. Neuropsychiatric Disease and Treatment 14, pages 2593-2598.
Read now
Raye Z. Litten, Bonnie B. Wilford, Daniel E. Falk, Megan L. Ryan & Joanne B. Fertig. (2016) Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety. Substance Abuse 37:2, pages 286-298.
Read now
Robin C Wackernah, Matthew J Minnick & Peter Clapp. (2014) Alcohol use disorder: pathophysiology, effects, and pharmacologic options for treatment. Substance Abuse and Rehabilitation 5, pages 1-12.
Read now

Articles from other publishers (20)

Brian J. Lopresti, Sarah K. Royse, Chester A. Mathis, Savannah A. Tollefson & Rajesh Narendran. (2022) Beyond monoamines: I. Novel targets and radiotracers for Positron emission tomography imaging in psychiatric disorders. Journal of Neurochemistry 164:3, pages 364-400.
Crossref
Bogusława Pietrzak, Agata Krupa-Burtnik & Ewa Zwierzyńska. (2023) The Effect of Zonisamide and Ethanol on Various Types of Memory in Rats. International Journal of Environmental Research and Public Health 20:3, pages 1815.
Crossref
Jasmine Turna, Sabrina K. Syan, Benicio N. Frey, Brian Rush, Mary Jean Costello, Mark Weiss & James MacKillop. (2019) Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review. Alcoholism: Clinical and Experimental Research 43:4, pages 550-563.
Crossref
Joshua A. Bornhorst & Gwendolyn McMillin. 2019. Critical Issues in Alcohol and Drugs of Abuse Testing. Critical Issues in Alcohol and Drugs of Abuse Testing 43 57 .
Megan M. Yardley & Lara A. Ray. (2016) Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models. Addiction Biology 22:3, pages 581-615.
Crossref
Raye Z. Litten, Daniel E. Falk, Megan L. Ryan, Joanne Fertig & Lorenzo Leggio. 2018. The Neuropharmacology of Alcohol. The Neuropharmacology of Alcohol 579 613 .
Uroš Klančar, Saša Baumgartner, Igor Legen, Polona Smrdel, Nataša Jeraj Kampuš, Dejan Krajcar, Boštjan Markun & Klemen Kočevar. (2014) Determining the Polymer Threshold Amount for Achieving Robust Drug Release from HPMC and HPC Matrix Tablets Containing a High-Dose BCS Class I Model Drug: In Vitro and In Vivo Studies. AAPS PharmSciTech 16:2, pages 398-406.
Crossref
Christopher J. Hammond, Mark J. Niciu, Shannon Drew & Albert J. Arias. (2015) Anticonvulsants for the Treatment of Alcohol Withdrawal Syndrome and Alcohol Use Disorders. CNS Drugs 29:4, pages 293-311.
Crossref
Clifford M. Knapp, Domenic A. Ciraulo, Ofra Sarid-Segal, Mark A. Richardson, Eric Devine, Chris C. Streeter, Marlene Oscar-Berman, Caitlin Surprise, Laurie Colaneri, Meghan Putnam, Megan Waters & Courtney Richambault. (2015) Zonisamide, Topiramate, and Levetiracetam. Journal of Clinical Psychopharmacology 35:1, pages 34-42.
Crossref
Kelly M. Youland, Ryan F. Miller, Lisa J. Mahoney, Andrew J. Borgert & Jacob D. Gundrum. (2014) Levetiracetam as Adjunctive Therapy for Acute Alcohol Withdrawal Syndrome in Hospitalized Patients. Journal of Clinical Psychopharmacology 34:6, pages 704-708.
Crossref
Carolina L. Haass-Koffler, Lorenzo Leggio & George A. Kenna. (2014) Pharmacological Approaches to Reducing Craving in Patients with Alcohol Use Disorders. CNS Drugs 28:4, pages 343-360.
Crossref
Karen Szumlinski & John J. Woodward. 2014. Neurobiology of Alcohol Dependence. Neurobiology of Alcohol Dependence 173 206 .
J Elliott Robinson, Meng Chen, Alice M Stamatakis, Michael C Krouse, Elaina C Howard, Sara Faccidomo, Clyde W Hodge, Eric W Fish & C J Malanga. (2013) Levetiracetam Has Opposite Effects on Alcohol- and Cocaine-Related Behaviors in C57BL/6J Mice. Neuropsychopharmacology 38:7, pages 1322-1333.
Crossref
Yann Le Strat. (2012) Levetiracetam in the Treatment of Alcohol Dependence: Toward the End of the Story?. Alcoholism: Clinical and Experimental Research 36:8, pages 1309-1310.
Crossref
Joanne B. Fertig, Megan L. Ryan, Daniel E. Falk, Raye Z. Litten, Margaret E. Mattson, Janet Ransom, William J. Rickman, Charles Scott, Domenic Ciraulo, Alan I. Green, Nassima A. Tiouririne, Bankole Johnson, Helen Pettinati, Eric C. Strain, Eric Devine, Mary F. Brunette, Kyle Kampman, David A. Tompkins & Robert Stout. (2012) A Double‐Blind, Placebo‐Controlled Trial Assessing the Efficacy of Levetiracetam Extended‐Release in Very Heavy Drinking Alcohol‐Dependent Patients. Alcoholism: Clinical and Experimental Research 36:8, pages 1421-1430.
Crossref
Christoph Richter, Susanne Effenberger, Tom Bschor, Udo Bonnet, Christian Haasen, Ulrich W. Preuss, Andreas Heinz, Anna Förg, Katharina Volkmar, Till Glauner & Martin Schaefer. (2012) Efficacy and Safety of Levetiracetam for the Prevention of Alcohol Relapse in Recently Detoxified Alcohol-Dependent Patients. Journal of Clinical Psychopharmacology 32:4, pages 558-562.
Crossref
Jennifer M. Mitchell, Leah E. Grossman, Allison R. Coker & Robert O. Messing. (2012) The Anticonvulsant Levetiracetam Potentiates Alcohol Consumption in Non-Treatment Seeking Alcohol Abusers. Journal of Clinical Psychopharmacology 32:2, pages 269-272.
Crossref
Kenneth R. Kaufman. (2011) Antiepileptic drugs in the treatment of psychiatric disorders. Epilepsy & Behavior 21:1, pages 1-11.
Crossref
Jadwiga Zalewska-Kaszubska, Bartosz Bajer, Elżbieta Czarnecka, Wanda Dyr & Dorota Gorska. (2011) Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol preferring rats chronically treated with levetiracetam: A preliminary study. Physiology & Behavior 102:5, pages 538-541.
Crossref
Lisa J. Merlo, Julia Arana & Amanda M. Stone. 2010. Clinical Trials in Psychopharmacology. Clinical Trials in Psychopharmacology 207 232 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.